Compounds > diclofenac
Page last updated: 2024-10-26

diclofenac and Focal Segmental Glomerulosclerosis

diclofenac has been researched along with Focal Segmental Glomerulosclerosis in 2 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ilatovskaya, DV1
Levchenko, V1
Ryan, RP1
Cowley, AW1
Staruschenko, A1
Sasdelli, M1
Cagnoli, L1
Donini, U1
Trombetta, N1

Trials

1 trial available for diclofenac and Focal Segmental Glomerulosclerosis

ArticleYear
[Sodium diclofenac in the therapy of idiopathic chronic glomerulonephritis].
    La Clinica terapeutica, 1980, May-31, Volume: 93, Issue:4

    Topics: Adolescent; Adult; Chronic Disease; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Femal

1980

Other Studies

1 other study available for diclofenac and Focal Segmental Glomerulosclerosis

ArticleYear
NSAIDs acutely inhibit TRPC channels in freshly isolated rat glomeruli.
    Biochemical and biophysical research communications, 2011, May-06, Volume: 408, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Glomerulosclerosis, Focal Segmental; I

2011